Literature DB >> 17904500

Social support and chronic kidney disease: an update.

Scott D Cohen1, Tushar Sharma, Kimberly Acquaviva, Rolf A Peterson, Samir S Patel, Paul L Kimmel.   

Abstract

Social support is an understudied, yet important, modifiable risk factor in a number of chronic illnesses, including end-stage renal disease (ESRD). Increased social support has the potential to positively affect outcomes through a number of mechanisms, including decreased levels of depressive affect, increased patient perception of quality of life, increased access to health care, increased patient compliance with prescribed therapies, and direct physiologic effects on the immune system. Higher levels of social support have been linked to survival in several studies of patients with and without renal disease. Higher perceived spousal support among women on dialysis was linked to improved compliance and survival in subgroup analyses. Few studies have examined the impact of social support interventions in ESRD patients. Studies have been limited by small sample size, retrospective analyses, and lack of control populations. Given the potential link with survival, a large, prospective, randomized controlled trial is needed to evaluate the impact of a social support group intervention in ESRD patients.

Entities:  

Mesh:

Year:  2007        PMID: 17904500     DOI: 10.1053/j.ackd.2007.04.007

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  55 in total

Review 1.  Modeling social influences on human health.

Authors:  Kate Karelina; A Courtney DeVries
Journal:  Psychosom Med       Date:  2010-11-19       Impact factor: 4.312

Review 2.  A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease.

Authors:  S Susan Hedayati; Venkata Yalamanchili; Fredric O Finkelstein
Journal:  Kidney Int       Date:  2011-10-19       Impact factor: 10.612

Review 3.  Social Determinants of Racial Disparities in CKD.

Authors:  Jenna M Norton; Marva M Moxey-Mims; Paul W Eggers; Andrew S Narva; Robert A Star; Paul L Kimmel; Griffin P Rodgers
Journal:  J Am Soc Nephrol       Date:  2016-05-13       Impact factor: 10.121

4.  The effect of social support and coping style on depression in patients with continuous ambulatory peritoneal dialysis in southern China.

Authors:  Jianxiong Lin; Qunying Guo; Xiaoqing Ye; Jianying Li; Chunyan Yi; Xiaodan Zhang; Xiaofeng Wu; Peiyi Cao; Xiaoli Yu; Lina Zhu; Xiaoyan Lin; Xiao Yang; Xueqing Yu
Journal:  Int Urol Nephrol       Date:  2012-10-11       Impact factor: 2.370

Review 5.  Depression and mortality in end-stage renal disease.

Authors:  Nisha Ver Halen; Daniel Cukor; Melissa Constantiner; Paul L Kimmel
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

6.  Peer Support and Mentorship in a US Rare Disease Community: Findings from the Cystinosis in Emerging Adulthood Study.

Authors:  Maya Doyle
Journal:  Patient       Date:  2015-02       Impact factor: 3.883

Review 7.  The psychosocial correlates of quality of life in the dialysis population: a systematic review and meta-regression analysis.

Authors:  Ramony Chan; Robert Brooks; Zachary Steel; Tracy Heung; Jonathan Erlich; Josephine Chow; Michael Suranyi
Journal:  Qual Life Res       Date:  2011-07-31       Impact factor: 4.147

8.  The relationship between social networks and pathways to kidney transplant parity: evidence from black Americans in Chicago.

Authors:  Teri Browne
Journal:  Soc Sci Med       Date:  2011-07-19       Impact factor: 4.634

9.  Oxytocin mediates social neuroprotection after cerebral ischemia.

Authors:  Kate Karelina; Kathleen A Stuller; Brant Jarrett; Ning Zhang; Jackie Wells; Greg J Norman; A Courtney DeVries
Journal:  Stroke       Date:  2011-09-29       Impact factor: 7.914

Review 10.  Assessing and improving the health-related quality of life of patients with ESRD.

Authors:  Fredric O Finkelstein; Kelli L Arsenault; Ana Taveras; Kwabena Awuah; Susan H Finkelstein
Journal:  Nat Rev Nephrol       Date:  2012-10-23       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.